Drug Study Zykast
Drug Study Zykast
DATE ORDERED
CLASSIFICATION
MECHANISM OF ACTION
Montelukast inhibits bronchoconstric tion due to antigen challenge. Montelukast is a selective leukotriene receptor antagonist of the cysteinyl leukotriene CysLT 1 receptor. The cysteinyl leukotrienes (LTC 4, LTD 4, LTE 4) are products of arachidonic acid metabolism that are released from various cells, including mast cells and eosinophils. They bind to cysteinyl leukotriene receptors (CysLT) found in the human airway.
SPECIFIC INDICATION Relief of symptoms associated w/ seasonal & perennial allergic rhinitis
CONTRAINDICATION
SIDE EFFECTS
NURSING PRECAUTION
ZYKAST
7/9/12
Anti-histamine
Asthenia / fatigue, fever, abdominal pains, trauma, dyspepsia, infectious gastroenteritis, dental pain, dizziness, headache, cough, nasal congestion, influenza, rash. Somnolence, dry mouth, hypersensitivity , convulsion, visual disturbances, palpitation, dyspnea, nausea, hepatitis, angioneurotic edema, pruritus, urticaria, myalgia, weight gain, abnormal liver function test.